// //
Skip to Content | Accesskey Details
Bringout the Health Within

Women Hesitant to Treat Everyday Aches Until “Bad Enough”

Safe, Natural Muscle Pain Reliever Now Widely Available

Newtown Square, Pa., Spring 2012—According to a recent research study,when it comes to muscle pain, most women suffer from low-grade aches and pains and are affected every day from common activities such as housework and yard work or from sitting at a computer too long.1 Despite having their mild pain cause them feelings of stress, frustration, depression, sluggishness and loss of control, these women hesitate to use pain relievers until the pain is “bad enough.” They don’t feel it’s healthy to take too many pain relievers.

Boiron’s Arnicare® Gel is fulfilling a niche for a safe, natural and reliable choice in the external pain category. As a homeopathic medicine, Arnicare works differently. Instead of masking problems, it works naturally with the body to relieve muscle pain, stiffness and swelling from injuries so sufferers can feel better faster naturally.

Research shows that pain affects women’s quality of life. Physically, they reported pain made them feel tired, low on energy, sluggish, run down and out of sync, making it more difficult to accomplish the many tasks they are required to complete on a daily basis. Emotionally, this slowdown leads to feelings of stress, frustration, depression, impatience, and being out of control and overwhelmed.1

Rather than waiting to treat the pain and putting their life on hold, women should treat pain at the first sign of symptoms before it gets in their way. Made from a natural active ingredient (Arnica montana, which is Latin for the Mountain daisy), Arnicare Gel is safe to use at the first sign of muscle pain.

This ties into a key trend unearthed by research concerning women’s shift in taking more preventative action and action at the first sign of a symptom, rather than waiting to treat a full-blown problem.2

Arnicare Gel is unscented, non-greasy and quickly absorbed by the skin, making it convenient and easy to use anywhere on the body. It’s also paraben-free. Therefore, there’s no reason for consumers to wait before using Arnicare Gel.

Additionally and uniquely, it provides the extra benefit of addressing bruises. Twenty-eight percent of women bruise easily, and eight percent of women would purchase a topical for bruising.

From the maker of Oscillococcinum® flu medicine, Boiron’s Arnicare line has grown into the number one homeopathic Arnica pain relief brand.2 It is the fastest-growing homeopathic topical pain relief brand in natural product stores3 and highly recommended by those who have tried it. Research show 72 percent of Arnicare awareness is driven by strong word-of mouth—50 percent of brand recommendations come from family and friends.

This non-prescription family medicine is now conveniently found at CVS, Rite Aid and Walgreens, as well as health food stores nationwide. Average retail price for a 2.6 oz tube is .99. Women can visit Arnicare.com for a coupon or to find the nearest store that carries Arnicare Gel.


  1. Boiron independent research—on file.
  2. “Identifying the Opportunities for Health and Wellness within the OTC Category,” conducted by The Hartman Group on behalf of Boiron, Jan. 2011, surveyed 2,055 women across the country ages 25–70 who are the primary shoppers for their household.
  3. SPINSscan Conventional (Powered by Nielsen Scantrack™); SPINSscan Natural Channel.

About Boiron: Boiron, world leader in homeopathic medicines, is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers. For more than 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.

Published: April, 2012